ArticleMelanoma management2025
Assessing patient risk, benefit, and outcomes in drug development: a decade of vemurafenib clinical trials.
Taylor Gardner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it